Literature DB >> 33301779

Polygenic risk scores for genetic counseling in psychiatry: Lessons learned from other fields of medicine.

E Eeltink1, M Z van der Horst2, J R Zinkstok3, C M Aalfs4, J J Luykx5.   

Abstract

Polygenic risk scores (PRS) may aid in the identification of individuals at-risk for psychiatric disorders, treatment optimization, and increase in prognostic accuracy. PRS may also add significant value to genetic counseling. Thus far, integration of PRSs in genetic counseling sessions remains problematic because of uncertainties in risk prediction and other concerns. Here, we review the current utility of PRSs in the context of clinical psychiatry. By comprehensively appraising the literature in other fields of medicine including breast cancer, Alzheimer's Disease, and cardiovascular disease, we outline several lessons learned that could be applied to future studies and may thus benefit the incorporation of PRS in psychiatric genetic counseling. These include integrating PRS with environmental factors (e.g. lifestyle), setting up large-scale studies, and applying reproducible methods allowing for cross-validation between cohorts. We conclude that psychiatry may benefit from experiences in these fields. PRS may in future have a role in genetic counseling in clinical psychiatric practice, by advancing prevention strategies and treatment decision-making, thus promoting quality of life for (potentially) affected individuals.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Breast cancer; Cardiovascular disease; Genetic counseling; Genetic testing; Polygenic risk score; Psychiatry

Mesh:

Year:  2020        PMID: 33301779     DOI: 10.1016/j.neubiorev.2020.11.021

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  5 in total

1.  Individualized Polygenic Risk Score Identifies NASH in the Eastern Asia Region: A Derivation and Validation Study.

Authors:  Feng Gao; Kenneth I Zheng; Sui-Dan Chen; Dong Hyeon Lee; Xi-Xi Wu; Xiao-Dong Wang; Giovanni Targher; Christopher D Byrne; Yong-Ping Chen; Won Kim; Ming-Hua Zheng
Journal:  Clin Transl Gastroenterol       Date:  2021-03-10       Impact factor: 4.396

2.  From Personalized Medicine to Precision Psychiatry?

Authors:  Eva Češková; Petr Šilhán
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-14       Impact factor: 2.570

Review 3.  Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe.

Authors:  Justo Pinzón-Espinosa; Marte van der Horst; Janneke Zinkstok; Jehannine Austin; Cora Aalfs; Albert Batalla; Patrick Sullivan; Jacob Vorstman; Jurjen J Luykx
Journal:  Transl Psychiatry       Date:  2022-10-11       Impact factor: 7.989

4.  Cannabis Use in People With Obsessive-Compulsive Symptomatology: Results From a Mexican Epidemiological Sample.

Authors:  Humberto Nicolini; José Jaime Martínez-Magaña; Alma Delia Genis-Mendoza; Jorge Ameth Villatoro Velázquez; Beatriz Camarena; Clara Fleiz Bautista; Marycarmen Bustos-Gamiño; Alejandro Aguilar García; Nuria Lanzagorta; María Elena Medina-Mora
Journal:  Front Psychiatry       Date:  2021-05-10       Impact factor: 4.157

Review 5.  Genomic and neuroimaging approaches to bipolar disorder.

Authors:  Mojtaba Oraki Kohshour; Sergi Papiol; Christopher R K Ching; Thomas G Schulze
Journal:  BJPsych Open       Date:  2022-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.